Since most of the CAD patients were treated with statins (commonly used as primary or secondary prevention measurement), we relied on a Mendelian randomization-based approach to study the impact of CETP and HDL-cholesterol on TMA and TMAO. This evidence concerns the gene CETP and coronary artery disorder.